Acesso livre
Acesso livre

Gestão de Antimicrobianos

Prevalência de rotulagem da alergia à penicilina variou de 0,9% a 10,2% entre práticas em uma ampla coorte pediátrica, levantando questões sobre a validade desses rótulos e o uso desnecessário de antibióticos de segunda linha que pode se seguir.

29 Mar, 2022 | 14:12h

Factors Associated With Penicillin Allergy Labels in Electronic Health Records of Children in 2 Large US Pediatric Primary Care Networks – JAMA Network Open

Conteúdos relacionados: A pharmacist-led penicillin allergy assessment program can delabel many “penicillin allergic” patients through allergy histories and penicillin skin testing. The program was associated with reduced use of high Clostridioides difficile infection–risk antibiotics.

M-A: Most patients with allergy to Penicillin can be given Cefazolin

Systematic review: Safety and efficacy of de-labelling penicillin allergy in adults using direct oral challenge

Penicillin allergy labels increase second-line broad-spectrum antibiotic prescribing for pediatric respiratory tract infections

Podcast: A Clinical Pharmacologist’s Perspective on Penicillin Allergy

Study: Development and Validation of a Penicillin Allergy Clinical Decision Rule

Consensus Recommendations: Management of a Surgical Patient with a Label of Penicillin Allergy

Practical Guide for Pharmacists to Successfully Implement Penicillin Allergy Skin Testing

NICE: Double Check Patients with ‘Penicillin Allergy’ to Avoid Increased MRSA Risk

Cohort Study: Risk of Meticillin Resistant Staphylococcus Aureus and Clostridium Difficile in Patients with a Documented Penicillin Allergy

 

Comentário no Twitter

 


M-A | Mortalidade da bacteriemia por Staphylococcus aureus.

25 Mar, 2022 | 15:31h

Staphylococcus aureus bacteremia mortality: A systematic review and meta-analysis – Clinical Microbiology and Infection


M-A | Rastreamento da tuberculose entre pacientes HIV-positivos internados.

25 Mar, 2022 | 15:30h

Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysis – The Lancet HIV

 

Comentário no Twitter

 


Estudo randomizado | Tratamento com dose única de anfotericina B lipossomal para meningite por criptococo.

25 Mar, 2022 | 15:01h

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis – New England Journal of Medicine (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

 


OMS lança diretrizes de tratamento clínico para influenza.

24 Mar, 2022 | 12:36h

Comunicado de imprensa: WHO releases clinical management guidelines for influenza – World Health Organization

Relatório original: Guidelines for the clinical management of severe illness from influenza virus infections – World Health Organization


Incidência de complicações oculares em pacientes com candidíase disseminada e implicações para a prática de exames oculares de rotina.

24 Mar, 2022 | 11:58h

The Incidence of Ocular Complications in Candidemic Patients and Implications for the Practice of Routine Eye Exams – Open Forum Infectious Diseases


Prevenção e tratamento do resfriado comum: quais são as evidências?

23 Mar, 2022 | 11:58h

Preventing and treating the common cold: what’s the evidence? – Evidently Cochrane

 

Comentário no Twitter

 


Genotipagem rápida no local de atendimento para evitar a ototoxicidade induzida por aminoglicosídio na UTI neonatal.

23 Mar, 2022 | 11:27h

Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care – JAMA Pediatrics

Editorial: Genetic Testing in Newborns Moves From Rare to Routine Application

 

Comentário no Twitter

 


Estudo randomizado | Contezolida oral vs. linezolida em adultos com infecções cutâneas e de partes moles complicadas.

21 Mar, 2022 | 15:58h

A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections – Journal of Antimicrobial Therapy (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

 


Antibioticoterapias para prevenir exacerbações agudas recorrentes da doença pulmonar obstrutiva crônica (DPOC): além das diretrizes.

17 Mar, 2022 | 12:43h

Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines – Respiratory Research


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.